IVERIC bio (ISEE) Misses Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
July 26, 2022 6:32 AM EDT- Zimura® GATHER2 Topline Data Expected in September of this Year-
- GATHER2 Patient Retention Continues to Exceed Expectations with a 12-Month Injection Fidelity Rate of 92.5%
- Agreement for up to $250 Million in Non-dilutive Debt Financing Secured -
- Exclusive License Entered into for Sustained Release Delivery Technology for Zimura® -
- Conference Call and Webcast Today, July 26, 2022, at 8:00 a.m. ET
PARSIPPANY, N.J.--(BUSINESS... More
